Thus, we need new more systematic studies to acquire high quality and relatively reliable data of prognostic and clinicopathological significance of MYC to stratify breast cancer patients who would benefit from MYC targeted therapy and provide evidence to prospective treatment. Here, MYC is linked to breast cancer.